Evidence map›Paper›PMID 36290089›Full record

ReviewAntibiotics (Basel, Switzerland)2022

Antibiotic Resistance to

Roberto Arrigoni, Andrea Ballini, Skender Topi, Lucrezia Bottalico, Emilio Jirillo, Luigi Santacroce

Open access · goldAbstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Historical and Social Considerations upon Tuberculosis.Journal of preventive medicine and hygiene · 2025
    Article
  7. Article
  8. Article
  9. Science advances · 2024
    Article
  10. Review
  11. Review
  12. Occurrence of multidrug-resistantVeterinary world · 2024
    Article
  13. Review
  14. Review
  15. The Dynamics of OXA-23 β-Lactamase fromInternational journal of molecular sciences · 2023
    Article
  16. Antibacterial and Antimycotic Activity ofPharmaceuticals (Basel, Switzerland) · 2023
    Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Roberto ArrigoniCNR Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), 70124 Bari, Italy.ORCID 0000-0001-5361-4346
Andrea BalliniDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.ORCID 0000-0001-8758-1415
Skender TopiDepartment of Clinical Disciplines, School of Technical Medical Sciences, "A. Xhuvani", 3001 Elbasan, Albania.
Lucrezia BottalicoDepartment of Clinical Disciplines, School of Technical Medical Sciences, "A. Xhuvani", 3001 Elbasan, Albania.ORCID 0000-0003-4176-3939
Emilio JirilloInterdisciplinary Department of Medicine, Section of Microbiology and Virology, School of Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.
Luigi SantacroceInterdisciplinary Department of Medicine, Section of Microbiology and Virology, School of Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.ORCID 0000-0001-5671-8124
University of Bari Aldo Moro · ITUniversity of Elbasan · ALInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies · ITUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTuberculosis (TB) is an infectious disease caused by the bacillus

Indexed as

antibiotic resistanceantibioticsimmunitymicrobiotamulti-drug resistant Mycobacterium tuberculosis strainsstringent response

Identifiers

PMID36290089
PMCPMC9598247
OpenAlexW4306736949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.